CEL-SCI Corp. (CVM)
5.12
-0.14
(-2.66%)
USD |
NYAM |
Jan 02, 15:39
CEL-SCI Cash from Investing (Quarterly): -0.0052M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | 0.296M |
| IGC Pharma, Inc. | -0.374M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Protalix Biotherapeutics, Inc. | -0.504M |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.671M |
| Cash from Financing (Quarterly) | 13.84M |
| Free Cash Flow | -17.15M |
| Free Cash Flow Per Share (Quarterly) | -0.5834 |
| Free Cash Flow to Equity (Quarterly) | -4.096M |
| Free Cash Flow to Firm (Quarterly) | -4.548M |
| Free Cash Flow Yield | -8.27% |